Drug
Sham/placebo
Sham/placebo is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Phase Distribution
Ph phase_2
2
50%
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 22 (50.0%)
N/A2 (50.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_2
Effects of Semaglutide on Nicotine Intake
NCT05530577
completedphase_2
Semaglutide for Alcohol Use Disorder
NCT05520775
completednot_applicable
Effect of Osteopathic Cranial Manipulative Medicine on Visual Function
NCT02728713
completednot_applicable
Effect of Cranial Osteopathy on Visual Function
NCT00510562
Clinical Trials (4)
Showing 4 of 4 trials
NCT05530577Phase 2
Effects of Semaglutide on Nicotine Intake
NCT05520775Phase 2
Semaglutide for Alcohol Use Disorder
NCT02728713Not Applicable
Effect of Osteopathic Cranial Manipulative Medicine on Visual Function
NCT00510562Not Applicable
Effect of Cranial Osteopathy on Visual Function
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4